Recent Patents on Inflammation & Allergy Drug Discovery
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 2
Author(s): Alexander K.C. Leung
Affiliation:
Export Options
About this article
Cite this article as:
Leung K.C. Alexander, Meet Our Editorial Board Member, Recent Patents on Inflammation & Allergy Drug Discovery 2016; 10 (2) . https://dx.doi.org/10.2174/1872213X1002170315211209
DOI https://dx.doi.org/10.2174/1872213X1002170315211209 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
10
Related Articles
-
Metabolic Syndrome in HIV-patients in Antiretroviral Therapy
Current HIV Research Bone Diseases Associated with Human Immunodeficiency Virus Infection: Pathogenesis, Risk Factors and Clinical Management
Current Molecular Medicine Chemical Senses Affecting Cough and Swallowing
Current Pharmaceutical Design Independent Relationship between Serum Osteocalcin and Uric Acid in a Cohort of Apparently Healthy Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets A Scientometrics Analysis and Visualization of Depressive Disorder
Current Neuropharmacology Editorial [Hot Topic: New Concepts of Angiotensin Receptor Blocker (ARB) in Atherosclerosis: ARB as a Metabolic-Improving Agent (Guest Editor: Minako Yamaoka-Tojo)]
Current Vascular Pharmacology TRPM Channels Phosphorylation as a Potential Bridge Between Old Signals and Novel Regulatory Mechanisms of Insulin Secretion
Current Diabetes Reviews Hyperfibrinogenemia is Significantly Associated with an Increased Risk of In-hospital Mortality in Acute Ischemic Stroke Patients
Current Neurovascular Research Adipokines: Therapeutic Targets for Metabolic Syndrome
Current Drug Targets Editorial:
Current Diabetes Reviews Novel Non-rodent Models of Kidney Disease
Current Molecular Medicine Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
Anti-Cancer Agents in Medicinal Chemistry Phenolic Compounds as Antioxidants: Carbonic Anhydrase Isoenzymes Inhibitors
Mini-Reviews in Medicinal Chemistry Plasminogen Activator Inhibitor with Very Long Half-life (VLHL PAI-1) can Reduce Bleeding in PAI-1-deficient Patients
Cardiovascular & Hematological Disorders-Drug Targets GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data
Current Alzheimer Research Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation
Combinatorial Chemistry & High Throughput Screening Current and Emerging Treatments for Metastatic Renal Cell Carcinoma
Current Cancer Drug Targets Pathogenicity of the 1918 Pandemic Influenza Virus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Mechanisms of Glucocorticoids Action: From Basic Research to Clinical Implications
Current Immunology Reviews (Discontinued) Mediterranean Diet and Longevity
Current Nutrition & Food Science